Endocannabinoid genetic variation enhances vulnerability to THC reward in adolescent female mice

Sci Adv. 2020 Feb 12;6(7):eaay1502. doi: 10.1126/sciadv.aay1502. eCollection 2020 Feb.

Abstract

Adolescence represents a developmental period with the highest risk for initiating cannabis use. Little is known about whether genetic variation in the endocannabinoid system alters mesolimbic reward circuitry to produce vulnerability to the rewarding properties of the exogenous cannabinoid Δ9-tetrahydrocannabinol (THC). Using a genetic knock-in mouse model (FAAHC/A) that biologically recapitulates the human polymorphism associated with problematic drug use, we find that in adolescent female mice, but not male mice, this FAAH polymorphism enhances the mesolimbic dopamine circuitry projecting from the ventral tegmental area (VTA) to the nucleus accumbens (NAc) and alters cannabinoid receptor 1 (CB1R) levels at inhibitory and excitatory terminals in the VTA. These developmental changes collectively increase vulnerability of adolescent female FAAHC/A mice to THC preference that persists into adulthood. Together, these findings suggest that this endocannabinoid genetic variant is a contributing factor for increased susceptibility to cannabis dependence in adolescent females.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aging / physiology*
  • Amidohydrolases / genetics
  • Animals
  • Axons / metabolism
  • Choice Behavior / drug effects
  • Dronabinol / pharmacology*
  • Endocannabinoids / genetics*
  • Female
  • Genetic Variation*
  • Male
  • Mice, Inbred C57BL
  • Nerve Net / drug effects
  • Nerve Net / physiology
  • Nucleus Accumbens / drug effects
  • Nucleus Accumbens / physiology
  • Polymorphism, Single Nucleotide / genetics
  • Receptor, Cannabinoid, CB1 / metabolism
  • Reward*
  • Tyrosine 3-Monooxygenase / metabolism
  • Ventral Tegmental Area / drug effects
  • Ventral Tegmental Area / physiology

Substances

  • Endocannabinoids
  • Receptor, Cannabinoid, CB1
  • Dronabinol
  • Tyrosine 3-Monooxygenase
  • Amidohydrolases
  • fatty-acid amide hydrolase